About Us
Raise Capital
Invest
News
FAQ
- For Companies
- For Investors
Login
Sign Up

About Us
Raise Capital
Invest
News
FAQ
- For Companies
- For Investors
Login
Sign Up

Recent Posts

Happy Fresh

Lorem ipsum dolor sit amet consectetur adipiscing elit sed do eiusmod tempor...
Liquidia Technologies

Lorem ipsum dolor sit amet consectetur adipiscing elit sed do eiusmod tempor...
Biolidics Limited

Lorem ipsum dolor sit amet consectetur adipiscing elit sed do eiusmod tempor...
Aggregate Asset Management

Lorem ipsum dolor sit amet consectetur adipiscing elit sed do eiusmod tempor...

Biolidics Limited

Published By: Admin

Published On: June 18, 2020

Published In: Funded Deals

Country

Singapore

Sector

Medical Technology

Funds Raised

SGD 4 Million

Deal Stage

Deal Type

Secondaries

Get the Latest Updates on Private Markets

Sign up for the newsletter today for the latest news, opportunities, and expert insights from us.

First Name

Last Name

Email

By submitting the details to us, you agree to comply with our Terms of Service and Privacy Policy.

© 2020 CapBridge. All rights reserved.

About us

CapBridge Financial
Careers
Raise Capital
Invest

News

Press Releases
Opinions
FAQ – For Companies
FAQ – For Investors

Legal

Risks
Privacy Policy
Terms of Service
Terms and Conditions

Connect

Get in Touch

Download the App

© 2020 CAPBRIDGE. All Rights Reserved. This website and its content are distributed by CapBridge Pte. Ltd. (Company UEN No. 201511511M), a capital markets services license holder regulated by the Monetary Authority of Singapore. The investment opportunities and products featured on our website are only available to the investors who have satisfied CapBridge Pte. Ltd.’s onboarding requirements for retail investors or investors which are “institutional investors” and “accredited investors”, in accordance with the Securities and Futures Act (Cap. 289) of Singapore.

The information about the investment opportunities and our products profiled on this website is provided for general information and marketing purposes only and should not be considered an inducement to engage in any investment activity. Nothing in this website is intended to be, and shall not be construed as, an offer to sell or a solicitation of an offer to purchase any securities or products where their offer or sale or use is not licensed, qualified or exempt from registration or permitted by law, or to any person to whom it would be unlawful to make such offer or solicitation.

Translations of this Site into languages other than English are intended solely for informational purposes and only provided as a convenience to non-English reading visitors, and shall not be legally binding nor have legal effect whatsoever under any applicable laws. While You may view this Site (and the Contents therein) in languages other than English, You understand and agree that the original and effective language for this Site (and any Content therein) is English. You therefore agree that We shall not be held liable to any person for any direct or indirect loss or injury caused in whole or in part by the incomplete or inaccurate translation of the original English text to any other language. Any translation that constitutes a departure from the English text should be disregarded. The translated version(s) is/are solely a courtesy and office translation for information purposes only and You cannot derive any rights from the translated version(s). In the event of a dispute about the Contents or interpretation of relevant terms or in the event of a conflict, ambiguity, inconsistency or discrepancy between the English version of this Site and the version in any other language, You understand and agree that the English version shall always apply, prevail and be conclusive and binding. The English version of this Site only shall be used in legal proceedings.

Contact Us